Severe Immune Thrombocytopenia (ITP)

By

Definition

Severe Immune Thrombocytopenia (ITP) is an autoimmune disorder characterized by:

  • A platelet count typically < 30,000/µL (often used clinically for “severe” disease)
  • Clinically significant bleeding, such as:
    • Mucosal hemorrhages (e.g., nosebleeds, gum bleeding)
    • Petechiae (small red spots on the skin)

In ITP, the immune system produces antibodies that destroy platelets, increasing the risk of serious internal bleeding.

Latest research: CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome

Clinical Features

Common Symptoms

Mucosal bleeding  

Petechiae 

 Purpura (easy bruising)

--------------------------------------------------------- 

 Additional Patient-Reported Symptoms

  • Fatigue
  • Memory and concentration difficulties

These non-bleeding symptoms can significantly impact quality of life, highlighting the need for holistic treatment approaches.

Risks and Complications

Patients with severe ITP are at risk of:

  • Spontaneous hematomas
  • Severe gastrointestinal bleeding
  • Intracranial hemorrhage (life-threatening brain bleeding)

Diagnosis of Thrombocytopenia

Definition of Thrombocytopenia

Thrombocytopenia is defined as:

  • Platelet count < 150,000/µL

Underlying Mechanisms

  • Reduced platelet production (thrombopoiesis)
  • Increased platelet destruction (e.g., autoimmune causes like ITP)

If all blood cell lines are reduced:

  • Decreased erythropoiesis (red cells)
  • Decreased leukopoiesis (white cells)
  • Decreased thrombopoiesis (platelets)

→ This suggests a broader bone marrow or hematopoietic disorder.

Classification of ITP by Duration

  • Acute ITP: < 3 months
  • Persistent ITP: 3–12 months
  • Chronic ITP: > 12 months

Refractory Severe ITP

  • Does not respond to standard treatments
  • May persist even after splenectomy

Treatment of Severe ITP

Due to bleeding risk, urgent treatment is required, typically including:

  • Corticosteroids
  • Intravenous immunoglobulin (IVIG)
  • Other immunosuppressive therapies

Treatment goals:

  • Prevent bleeding
  • Increase platelet count
  • Improve quality of life

Acquired vs. Inherited Thrombocytopenia

Acquired Thrombocytopenia

  • Develops due to external factors:
    • Autoimmune diseases (e.g., ITP)
    • Medications
    • Infections

Inherited Thrombocytopenia

  • Genetic condition present at birth
  • Often features large platelets (macrothrombocytopenia)
  • Can be misdiagnosed as ITP

Misdiagnosis may lead to unnecessary immunosuppressive treatment

Drug-Induced Thrombocytopenia

Certain medications can cause low platelet counts. These include:

  • Some antibiotics
  • Heparin
  • Antiepileptic drugs
  • Chemotherapy agents

Dietary Considerations in Thrombocytopenia

To reduce bleeding risk, patients may be advised to avoid or limit:

Foods/Substances That May Affect Platelets

  • Alcohol
  • Quinine (found in tonic water)
  • Garlic
  • Onions
  • Ginger
  • Turmeric

Other Dietary Factors

  • Processed foods
  • High-sugar items
  • Trans fats

Some foods rich in antioxidants (e.g., blueberries, red grapes) may influence platelet function, though evidence is limited.

Key Takeaways

  • Severe ITP involves very low platelet counts and active bleeding risk
  • It is an autoimmune condition requiring prompt treatment
  • Diagnosis requires distinguishing it from other causes of thrombocytopenia
  • Management should address both bleeding symptoms and quality of life

References:

Immune Thrombocytopenia https://www.ncbi.nlm.nih.gov/books/NBK562282/

When you have ITP, the immune system is out of balance in more ways than one
https://www.wayrilz.com/us/what-is-itp

Refractory severe idiopathic thrombocytopenia and treatment challenges
https://pmc.ncbi.nlm.nih.gov/articles/PMC10129162/

Thrombocytopenia https://www.youtube.com/watch?v=i_c8x7TiHN0

Immune thrombocytopenia (ITP)
https://www.rarediseaseadvisor.com/hcp-resource/immune-thrombocytopenia-diet-nutrition/

Definition der ITP (German)
https://pro.campus.sanofi/de/immunthrombozytopenie-itp/wissen/itp-definition

Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021;96(2):188-198.

 

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9  

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more